PharmaLogic buys Lantheus’s radiopharmaceutical CDMO business. PharmaLogic Holdings said on November 9 it will acquire Lantheus’s contract development and manufacturing business and its Springfield, New Jersey facility, for undisclosed terms. The site’s team joins Agilera, PharmaLogic’s therapeutic CDMO franchise, on closing, and a long term supply agreement has Agilera manufacturing lutetium Lu 177 dotatate, sold by Lantheus as Bravnetsa, after its final FDA approval in September 2026. Lantheus bought the facility only in April 2025, inside its Evergreen Theragnostics acquisition, and is itself the target of Curium’s proposed acquisition valued at up to 8 billion dollars. The transaction needs regulatory review and has no announced closing date.
Google launches Gemini for healthcare in United States preview. Google Cloud announced Gemini for healthcare on November 10, an agent that connects electronic health records, billing, clinical guidelines and Medicare data to summarize records, prepare visits, check coverage and draft prior authorizations. Connectors to Epic and Oracle Health records are read only, so clinicians keep every change to the chart. Launch partners named in coverage of the announcement include HCA Healthcare, Highmark Health, Northwell Health and Optum. Google published no pricing, no general availability date and no measured time savings; its case rests on the nearly 28 hours a week it says clinicians spend on paperwork. Endpoints News covered the launch on November 12 as Google entering a health AI field already occupied by Microsoft, Amazon, Anthropic and OpenAI offerings.
First complete reference genomes for neglected malaria parasites. Researchers at the Wellcome Sanger Institute and the Parasites and Microbes Research and Training Center in Mali have produced chromosome level reference genomes for Plasmodium ovale wallikeri and Plasmodium malariae, alongside P. falciparum, sequenced directly from blood samples from natural infections in Faladie, Mali, without laboratory culture. The study, published in PLOS Pathogens and reported November 12, used PacBio long read sequencing and Hi-C capture to resolve previously inaccessible subtelomeric regions holding gene families tied to immune evasion and persistence. The two neglected species have lacked reference genomes because they are hard to culture; the assemblies are now the baseline for comparative work on transmission and drug response.